Drug Research
Biophore India gets DCGI nod to manufacture COVID drug Favipiravir API
Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir, an active pharmaceutical ingredient (API), used in the finished formulation to treat mild to moderate COVID-19 cases. Besides DCGI’s...
Drug Research
Vetter Further Expands its Development Service with New Site in Austria
With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions. Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) is further...
Drug Research
Vetter and Rentschler Biopharma team up to simplify processes and optimize time-to-market
With drug development growing increasingly complex and cost-intensive, biopharmaceutical companies are under significant pressure to streamline their products’ path to market. The desired goal of the collaboration is to create long-term value through the alignment of manufacturing approaches that...
Drug Research
CIRION BioPharma Research Expands its Bioanalytical Services and Offers SARS-CoV-2 and COVID-19 Antibodies Testing Services
CIRION Research Inc., a leading provider of large molecule bioanalytical testing and global central laboratory services, announced that the company is now offering new testing services for the screening and clinical diagnosis of COVID–19 and expands its existing laboratory...
Drug Research
BioInvent extends research collaboration and license agreement with Pfizer Inc
BioInvent International AB announces that it has further extended the research term under its cancer immunotherapy research collaboration and license agreement with Pfizer Inc. until the end of 2020.
In December 2016, the companies entered into the agreement for the...
Drug Research
Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems
Abbott and Tandem Diabetes Care announced that they have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's world-leading1 continuous glucose monitoring (CGM) technology with Tandem's innovative insulin delivery systems to provide more options for...
Drug Research
Stevanato Group signs an agreement with the CEPI to provide pharma glass vials for 2 billion doses of COVID-19 vaccines under development
Italy-based Stevanato Group, a leading producer of pharmaceutical glass containers and integrated provider of drug delivery systems, and CEPI (the Coalition for Epidemic Preparedness Innovations) - the global partnership at the forefront of funding and coordinating the development of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.